We are live on ! Find out more
AMBI

Ambit Biosciences Corp
AMBI

Delisted

AMBI was delisted on the 10th of November, 2014.

Back to rankings

0 hedge funds and large institutions have $0 invested in Ambit Biosciences Corp in 2014 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 49 → 0 (-49)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $154M → $0 (-$154M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 48

Holders
–
Holders Change
-49
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
FCMI
Foresite Capital Management I
California
-$32M
2
AC
Aisling Capital
New York
-$25.4M
3
O
OrbiMed
New York
-$23M
4
BBA
Baker Bros. Advisors
New York
-$16.8M
5
GPP
Great Point Partners
Connecticut
-$9.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMI
1
Foresite Capital Management I
California
– -$32M -2,079,569 Closed
AC
2
Aisling Capital
New York
– -$25.4M -1,650,156 Closed
O
3
OrbiMed
New York
– -$23M -1,490,769 Closed
BBA
4
Baker Bros. Advisors
New York
– -$16.8M -1,093,332 Closed
GPP
5
Great Point Partners
Connecticut
– -$9.24M -600,000 Closed
GCM
6
Gruss Capital Management
New York
– -$6.83M -443,318 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$4.35M -282,451 Closed
GP
8
GLG Partners
United Kingdom
– -$2.77M -180,000 Closed
COPPSERS
9
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$2.66M -172,560 Closed
AQR Capital Management
10
AQR Capital Management
Connecticut
– -$2.48M -160,924 Closed
JP Morgan Chase
11
JP Morgan Chase
New York
– -$2.43M -158,053 Closed
SAM
12
Sectoral Asset Management
Quebec, Canada
– -$2.25M -146,111 Closed
LOM
13
Loeb Offshore Management
New York
– -$2.15M -139,510 Closed
WIC
14
Water Island Capital
New York
– -$1.95M -126,415 Closed
GF
15
Gabelli Funds
New York
– -$1.54M -100,000 Closed
PAMP
16
Polar Asset Management Partners
Ontario, Canada
– -$1.54M -100,000 Closed
B
17
Bailard
California
– -$1.43M -93,000 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$1.36M -88,336 Closed
TL
19
TowerView LLC
New York
– -$1.29M -83,762 Closed
Macquarie Group
20
Macquarie Group
Australia
– -$1.18M -76,500 Closed
GI
21
GAMCO Investors
Connecticut
– -$762K -49,500 Closed
Geode Capital Management
22
Geode Capital Management
Massachusetts
– -$696K -45,200 Closed
BCM
23
Bridgeway Capital Management
Texas
– -$695K -45,100 Closed
Jane Street
24
Jane Street
New York
– -$682K -44,299 Closed
HM
25
Harvest Management
New York
– -$613K -39,800 Closed
1
2

AMBI Hedge Fund Activity: Q4 2014 in Review

0 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Ambit Biosciences Corp (AMBI) for Q4 2014, worth a combined $0 — down 100% from $154M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of AMBI and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Foresite Capital Management I, exiting entirely with an estimated $32M sold.

  • 0 institutional investors held Ambit Biosciences Corp (AMBI) as of Q4 2014, down from 49 in Q3 2014.
  • Funds reported $0 of Ambit Biosciences Corp stock for Q4 2014, down 100% quarter-over-quarter.
  • 0 funds opened new Ambit Biosciences Corp positions in Q4 2014 and 48 closed out, a net change of -48 holders.
  • The largest Ambit Biosciences Corp seller in Q4 2014 was Foresite Capital Management I, an estimated $32M sold.

Based on aggregated 13F filings for Q4 2014.